Cleared Traditional

ArtiFascia

K223445 · Nurami Medical , Ltd. · Neurology
Aug 2023
Decision
269d
Days
Class 2
Risk

About This 510(k) Submission

K223445 is an FDA 510(k) clearance for the ArtiFascia, a Dura Substitute (Class II — Special Controls, product code GXQ), submitted by Nurami Medical , Ltd. (Haifa, IL). The FDA issued a Cleared decision on August 10, 2023, 269 days after receiving the submission on November 14, 2022. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5910.

Submission Details

510(k) Number K223445 FDA.gov
FDA Decision Cleared SESE
Date Received November 14, 2022
Decision Date August 10, 2023
Days to Decision 269 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXQ — Dura Substitute
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5910

Similar Devices — GXQ Dura Substitute

All 42
Collagen Dura Regeneration Membrane - Repair
K251191 · Collagen Matrix, Inc. · Nov 2025
Helios Dura Regeneration Matrix
K250420 · Helios Biomedical, Inc. · May 2025
SyntheCel Dura Repair
K212943 · Synthes USA Products, LLC · Jan 2022
XenoSure Dura Biologic Patch
K183513 · LeMaitre Vascular, Inc. · Jun 2019
Cerafix Dura Substitute
K172603 · Acera Surgical, Inc. · Nov 2017
DuraGen Secure Dural Regeneration Matrix
K163456 · Integra LifeSciences Corporation · Jan 2017